登录

XIShine Smart Healthcare Closes $10M Angel Round of Financing

作者: Mailman 2021-01-18 17:28
熙象科技
企业数据由 动脉橙 提供支持
医养机器人研发商 | 天使轮 | 运营中
中国-上海
2021-01-18
融资金额:近千万人民币
九和堂中医药
查看

(VCBeat) Jan. 18, 2021 -- Xixiang (Shanghai) Technology Co., Ltd. ("XIShine Smart Healthcare") announced the closing of angel round financing worth nearly 10 million yuan, with participation from Shanghai Jiuhetang Traditional Chinese Medicine Co., Ltd. ("Jiuhetang Group") and Xiamen Pidao co-investment. the fresh round of funding will be used towards the R&D of new-generation products and the construction of the digital service system.


Founded in 2017, XIShine Smart Healthcare is a technology company engaged in the R&D of AI-driven medical robots. Starting with intelligent robots, the company has successfully developed Zhiyi Shiguang Series moxibustion robot. The moxibustion robot has been piloted and upgraded for two generations of products. Meanwhile, a comprehensive service process and market promotion model has been formed and has been well praised by customers in many provinces across China. At present, the R&D of the third generation robot of XIShine Smart Healthcare is also progressing smoothly.


"With the precise service and price advantage of the robot, the moxibustion will benefit more people, which is not only the needs of the elderly but also my dream." "Said Chen Hanbin, founder of XIShine Smart Healthcare.


After two years of in-depth research on elderly-care institutions, healthcare institutions, and traditional Chinese medicine hospitals, and discussion with experts from Beijing University of Chinese Medicine and others, through the development and testing of products and projects, Chen Hanbin determined intelligent moxibustion robot as the final product to be developed. He believes that the introduction of technologies in traditional Chinese medicine in the new healthcare service market has great prospects.


After years of optimization and feedback from experts, the moxibustion robot now has three features, including programmed and customized moxibustion technique, automatically purifying moxibustion smoke, and providing personalized precision moxibustion healthcare program based on data.


Chen Hanbin said that beginning in 2021, in addition to accelerating the development of a new generation of robots and digital service system construction, XIShine Smart Healthcare will also seek market cooperation, supporting more moxibustion healthcare institutions, and strive to become China's largest and most professional provider of new healthcare solutions based on moxibustion robots.


>>>>

About Jiuhetang Group 


Founded in 1933, Jiuhe Tang Group has been famous in Shanghai since its inception for its genuine and considerate treatment using herbs. In 2011, the company was awarded the title of "China Time-honored Brand" by the Ministry of Commerce (China), which is deeply trusted by consumers and has won policy support from the government. 


At present, Jiuhetang Group has built a medical and health industry chain integrating healthcare services, pharmaceutical supply chain system, health management and self-developed products.

注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

2023数字医疗年度创新白皮书:近百政策及审批昭示落地加速,半数融资关联人工智能

脑科学、数字疗法快速渗透,千亿规模的康复市场正在被唤醒 | 2021年度盘点

受《浪潮之巅》启发,脉景用AI打造“活的中医大脑”

泉脉健康:基于中医AI,构建“健康管理-保险-基层医疗” 生态

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

慧渡医疗入选肿瘤液态活检创新公司全球前五强

2021-01-18
下一篇

He-man Gene Announces Closing Angel Round of Millions of RMB

2021-01-18